Announcement on Reply to "Letter of Supervision on Information Disclosure of 2023 Annual Report of Kangmei Pharmaceutical Co.,Ltd" from SSE
· Issued by Kangmei Pharmaceutical Co., Ltd Class A via Shanghai Stock Exchange
Announcement on Reply to "Letter of Supervision on Information Disclosure of 2023 Annual Report of Kangmei Pharmaceutical Co.,Ltd" from SSE
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View AttachmentCompany analysis
